A team of students from Rice University won Accenture’s 2023 Innovation Challenge with extended reality project. Photo via accenture.com

A team of students from Rice University may see their award-winning idea incorporated into programming from the nonprofit Smithsonian Institution — the world’s largest museum, education, and research complex.

Rice’s Team Night Owls, made up of four undergraduates, recently won Accenture’s 2023 Innovation Challenge. The team’s winning concept: a three-month, six-town mobile bus exhibit designed to expose the Smithsonian to residents of rural areas in the U.S. One of the highlights of the exhibit would be an augmented reality/virtual reality feature.

The Rice team competed against more than 1,100 applicants. Participants were asked to “envision ways to deliver the spirit and wonder of in-person visits” at the Smithsonian to rural communities nationwide.

“Our biggest takeaway from the challenge was learning how to generate innovative ideas and then combine the best aspects from each one to include into one coherent solution,” says one of the team members, Sean Bishop.

Accenture is providing pro bono support to the Smithsonian to help turn the Rice team’s “Rural Routes” concept into reality. Ideally, the Smithsonian hopes to incorporate the team’s idea into its 2026 celebration of the country’s 250th birthday.

Officials say they liked the Rice team’s proposal because it would be a way for the organization to familiarize rural America with the Smithsonian while also collecting and displaying the stories of rural residents.

“We hope to amplify the voices of rural Americans and raise the visibility of their cultural stories,” the Smithsonian says in a statement provided to InnovationMap.

Nico Motta, a rising junior studying business and data science at Rice, says his team’s idea was born out of a desire to bring the Smithsonian to people and bring people to the Smithsonian.

“From there, two different ideas emerged that we eventually brought together. First, we connected the idea of campaign buses that allow political candidates to travel to smaller communities,” Motta tells InnovationMap. “Second, we researched existing Smithsonian initiatives and were intrigued by the Crossroads program, a stationary exhibit shipped out to community centers.”

The team then brainstormed ways to marry the two ideas. The result: the Rural Routes project.

Aside from Motta and Bishop, members of the Rice team are Eva Moughan, a rising junior studying math and operations research at Rice, and Austin Tran, a rising junior studying business and statistics.

Bishop, a rising senior studying chemical and biomolecular engineering at Rice, says the Rural Routes entry stood out partly because the team:

  • Dug into how to finance the exhibit.
  • Supplied examples of similar projects that have achieved success.
  • Folded augmented reality/virtual reality into the project.

Organizers believe the Rice team’s winning entry embodies the competition’s goal this year to generate “bold ideas and innovative thinking” about introducing more Americans to the Smithsonian.

“The Accenture Innovation Challenge invites students seeking to do well and do good to collaborate on solving real and real-time business challenges for leading nonprofits. The students’ innovative ideas make the nonprofit better able to achieve its mission, and together we work to implement the winning solution,” says Marty Rodgers, senior managing director of Accenture’s U.S. south region and executive sponsor of the Accenture Innovation Challenge.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

7+ can't-miss Houston business and innovation events in June 2026

where to be

Editor's note: The FIFA World Cup comes to Houston this month, joined by major energy conferences and a lineup of fan-favorite, recurring events. Here’s what not to miss and how to register. Please note: this article may be updated to add more events.


June 1-4 — CLEANPOWER 2026 Conference and Exhibition

CLEANPOWER unites policymakers, experts, and corporate leaders to solve the challenges that none can solve alone. This must-attend, four-day conference is packed with cutting-edge discussions about wind, solar, storage, and transmission; dealmaking; networking; and fun.

This event begins June 1 at the George R. Brown Convention Center. Register here.

June 2 — Humans of Healthcare

Houston Methodist Center for Innovation will present its quarterly speaker series, Humans of Healthcare. The series will feature a panel of experts who will share about their career paths and discuss the nuances of the health care industry. This month's session will focus on today’s nursing landscape, the industry’s expectations of nurses and what career paths are possible in the field.

The event is Tuesday, June 2, from 5-6:30 p.m. at the Ion. Register here.

June 9 — Greentown Go Make Kickoff

Head to the Ion to celebrate the Greentown Go Make 2026 cohort. The open-innovation program with Shell Catalysts & Technologies and Technip Energies focuses on catalytic solutions for industrial decarbonization and the energy transition. Hear pitches from the founders and network with a select group of startups while enjoying food and drink.

This event is Tuesday, June 9, from 5:30-8 p.m. Register here.

June 9-10 — Texas Brain Economy Summit

The Center for Houston’s Future and UTMB are bringing the Texas Brain Economy Summit back to Houston this summer to continue to position the region as a global leader in brain health. Expect to hear from leaders of global institutions, including the World Economic Forum, U.S. Chamber of Commerce, McKinsey Health Institute, Global Brain Economy Initiative, Davos Alzheimer’s Collaborative, Business Collaborative for Brain Health (UsAgainstAlzheimer’s), Rice University, Memorial Hermann, MD Anderson and many others. Read InnovationMap's full preview of the event here.

This event begins Tuesday, June 9. Purchase tickets here.

June 10 — MIT Future of Healthcare Technology Forum

The MIT Club of South Texas will host an in-person forum to explore how innovation, government and policy are changing the healthcare industry. The event will feature MIT alumni and Houston healthcare leaders, including Dr. Tim Boone, dean of the Texas A&M School of Engineering Medicine; Cynthia Reinhart-King, chair of bioengineering at Rice University; Dr. Tony Lin, CEO and chairman emeritus of Kelsey-Seybold Clinic; and others.

This event is Wednesday, June 10, from 5:15-8:30 p.m. at the TAMU EnMed Building. Register here.

June 11 — Goals & Gigawatts: Houston Energy & Climate Week The Power of & Kickoff Party

Come watch the Mexico City FIFA opening match while celebrating energy and innovation at the Goals & Gigawatts Kickoff Party. The event will feature food, drinks, and a showcase on Houston Energy & Climate Week. Learn what to expect and how to get involved in HECW before closing the night with a DJ and karaoke.

This event is Thursday, June 11, from 1:30-6:30 p.m. Find more information here.

June 16-17 — Energy Projects Conference & Expo

The Energy Projects Conference & Expo (EPC Show) is the largest event in North America for professionals working at the heart of major energy projects. The essential event for engineering, construction, commissioning, operations and maintenance across multiple energy sectors brings together five leading conferences under one roof. Conference subjects span LNG exporting, hydrogen and ammonia, midstream, petrochem and refining, and sustainable aviation fuels.

This event begins June 16 at George R. Brown Convention Center. Register here.

June 25 – NASA Tech Talk

Every fourth Thursday of the month, NASA experts, including longtime engineer Montgomery Goforth, present on technology development challenges NASA’s Johnson Space Center and the larger aerospace community are facing, and how they can be leveraged by Houston’s innovation community. Stick around after for drinks and networking at Second Draught.

This event is Thursday, June 25, from 6-7 p.m. at the Ion. Register here.

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”